Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis”

1,268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,268 results

Early research (Phase 1)Ended earlyNCT00030381
What this trial is testing

Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT01814839
What this trial is testing

A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers

Who this might be right for
TTR-mediated Amyloidosis
Alnylam Pharmaceuticals 85
Large-scale testing (Phase 3)Active Not RecruitingNCT05463731
What this trial is testing

Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,667
Testing effectiveness (Phase 2)Study completedNCT00003853
What this trial is testing

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)Ended earlyNCT04973137
What this trial is testing

Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Prothena Biosciences Ltd. 208
Early research (Phase 1)Study completedNCT06397001
What this trial is testing

Treatment of AA Amyloidosis

Who this might be right for
AA Amyloidosis
Nelson Leung, MD 1
Not applicableStudy completedNCT04068077
What this trial is testing

Application of High Resolution Optical Coherence Tomography in Skin Disease: Amyloidosis and Differential Diagnosis

Who this might be right for
Amyloidosis
Taipei Veterans General Hospital, Taiwan 50
Not applicableWithdrawnNCT02664571
What this trial is testing

Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis

Who this might be right for
Amyloid Cerebral AngiopathyAlzheimer Disease
Centre Hospitalier Universitaire de Nīmes
Post-approval studies (Phase 4)Study completedNCT05121909
What this trial is testing

Experimental Mouthwashes

Who this might be right for
GingivitisPlaque
Johnson & Johnson Consumer Inc. (J&JCI) 274
Large-scale testing (Phase 3)Study completedNCT01004406
What this trial is testing

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I

Who this might be right for
Acute Coronary Syndrome
VA Office of Research and Development 59
Not applicableUnknownNCT01856699
What this trial is testing

Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy

Who this might be right for
Intracerebral HemorrhageCerebral Amyloid AngiopathyIschemic Stroke
Ludwig-Maximilians - University of Munich 302
Testing effectiveness (Phase 2)WithdrawnNCT05486481
What this trial is testing

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Who this might be right for
AL AmyloidosisLight Chain (AL) AmyloidosisSystemic Light Chain Disease
Alfred Chung, MD
Testing effectiveness (Phase 2)Study completedNCT01284387
What this trial is testing

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 126
Post-approval studies (Phase 4)Study completedNCT04828993
What this trial is testing

The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

Who this might be right for
Transthyretin Amyloid Polyneuropathy (ATTR-PN)
Pfizer 15
Not applicableStudy completedNCT02338427
What this trial is testing

Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis

Who this might be right for
Amyloidosis
Centre Hospitalier Departemental Vendee 140
Large-scale testing (Phase 3)Looking for participantsNCT07207811
What this trial is testing

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S 1,280
Not applicableLooking for participantsNCT06933212
What this trial is testing

Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.

Who this might be right for
Cerebral Amyloid AngiopathyCAA - Cerebral Amyloid Angiopathy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 86
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)WithdrawnNCT05728736
What this trial is testing

Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau

Who this might be right for
Alzheimer Disease
Brendan Lucey
Not applicableUnknownNCT03984877
What this trial is testing

Impact of Amyloidosis on TAVI Patients

Who this might be right for
Valve Stenoses, AorticAmyloidosis Cardiac
Javier López Pais 320
Load More Results